Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • menenuh
    Junior Member
    • Jan 2010
    • 8

    #1

    "beginner in alignment" question

    Hello,
    I am analyzing Roche 454 sequence data. The sequencing was performed not for whole genome but for the exons of (around) 100 genes. When I first started analyzing, I used the target sequence (exome of 100 genes) as my reference not the whole genome. After all, this target region is tiled and sequenced by Roche platform. But by doing so I am getting a lot of consequential SNPs, most of them are probably false positives.
    But when I perform whole genome alignment, I am getting reasonable/low number of SNPs.
    I checked some specific regions which are showing great variation at the number of SNPs. Turns out, some of the reads mapping to that region in the 1st alignment are not mapping there in whole genome alignment, but to some other region which is not in the target sequence.
    So my questions are;
    Is it general practice to do whole genome alignment in any given NGS project, or do I need more stringent alignment parameters when performing alignment over a specific region?
    By the way, I am using bwa and ssaha2 for alignment step.

    Thanks!
  • bioinfosm
    Senior Member
    • Jan 2008
    • 483

    #2
    I noticed similar behavior looking at capture illumina reads. The capture is not very specific and there is always a lot of 'off-target' sequencing that occurs. In case of using a restricted reference sequence, a lot of those 'off-target' reads are forced to align to these regions, producing false variants.

    The best approach is to use the whole genome for the mapping of reads.
    --
    bioinfosm

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    17 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    35 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...